Enhanced lethality for BALB/c mice has been observed after the administration of Salmonella typhosa endotoxin with either actinomycin D, cycloheximide, or nogalamycin. The 
LD50 of endotoxin in normal mice was 12 mg/kg and in mice given 0.4 mg of actinomycin D per kg was 0.067 mg/kg. The LD50 of actinomycin D in mice administered 1 Synergy was determined by analyzing isobolograms (10) and by using the method of Treffers and Muschel (12) . The amount of drug that killed 50% of the treated animals (LDso) was determined by the method . of Reed and Muench (9) or, where applicable, by in------.-----terpolation from probit plots (6) . Potency ratios and tests for parallelism were determined by the method of Litchfield and Wilcoxon (6) . The acceptable level of significance was P < 0.05.
Pretreatment of mice with S. typhosa endotoxin involved the following regimen: 2 mg of endotoxin per kg on day -5, 4 mg of endotoxin per kg on days -4 and -3, and 8 mg of endotoxin per kg on day -2. The mice were challenged on day 0.
RESULTS
The LD,% of actinomycin D for BALB mice 3
.
. (Fig. 4) ; 120 mg of cycloheximide per kg was nonlethal. The LD50 of endotoxin for mice during this period of experimentation was 20.5 mg/kg by Reed-Muench determination and 18.5 mg/kg by probit analysis (Fig. 5 ). When administered with 120 mg of cycloheximide per kg, the LD50 of endotoxin after 3 days was decreased to 0.02 mg/kg, representing a 925-fold potentiation (Fig. 5) (Fig. 7) . The LD5o of endotoxin for mice dur- ing this period of experimentation was 17.9 mg/ kg as calculated by the Reed-Muench method and 17.5 mg/kg by probit analysis (Fig. 8) . The LD50 of endotoxin, scored on day 3, was reduced to 0.2 mg/kg when mice were simultaneously administered 20 mg of nogalamycin per kg, thus representing an 88-fold potentiation (Fig. 8) . It should be noted that, when given alone, 20 mg of nogalamycin per kg resulted in only 3 % lethality. Other nogalamycin-endotoxin combinations likewise resulted in enhanced lethalities. The 7 day LD50 of nogalamycin was reduced from 21 mg/kg to 13.2 mg/kg when administered to mice in combination with 1 mg/kg of endotoxin (Fig. 7) , thus representing a 1.6-fold potentiation. The lethality due to various combinations of nogalamycin and endotoxin was greater after 3 days than the additive effects of the corresponding drug doses (Fig. 9) .
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DISCUSSION
The previously reported potentiation of mouse lethality due to simultaneous administration of combinations of actinomycin D and endotoxin has been confirmed (1, 3, 7) . The smaller potentiation of endotoxicity observed by us may be due to any number of factors including, strain and sex of mice, source and dose of antibiotic, The lethal responses to combinations of nogalamycin and endotoxin are not parallel to the lethal responses for endotoxin alone but are parallel (P < 0.05) to the lethal responses for the antibiotic alone. Moreover, deaths due to endotoxin occur during the first 48 hr after administration, whereas deaths due to nogalamycin and combinations of nogalamycin and endotoxin occur up to 7 days after injection. These data indicate that the nogalamycin-endotoxin interactions resulting in enhanced lethality are mainly due to a potentiation of the antibiotic's mode of injury.
The questions remains: does the antibiotic retard the clearance or detoxification of endotoxin, or both? Conversely, endotoxin may retard the clearance or detoxification of the antibiotic. The data presented suggest that both processes may be involved, depending upon the synergy being studied.
